E. V. Akatova

E. V. Akatova

Auto-generated profile, based on publicly available information

E. V. Akatova

Russian University of Medicine

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2024 in Modern Rheumatology Journal
Verified
Journal Article
Open access
PDF file
EAE. V. Akatova
E. V. Akatova
YBYu. S. Bakhareva
Yu. S. Bakhareva
OBO. V. Bugrova
O. V. Bugrova
IVI. B. Vinogradova
I. B. Vinogradova
EGElena Gerasimova
Elena Gerasimova
ИЮИ. Ю. Юнонин
И. Ю. Юнонин
The article discusses the results of a comparative phase III clinical trial of the efficacy and safety of the biosimilar Complarate (CPR; JSC Generium, Russia) and the reference drug Actemra (ACT; F. Hoffmann-La Roche Ltd., Switzerland) to assess their equivalence in patients with rheumatoid arthritis, RA (NCT06475508 clinicaltrials.gov).Materials and methods. Male and female patients aged 18–75 years with RA with moderate to high disease activity and insufficient response to methotrexate (MTX) monotherapy and/or poor tolerability of MTX and/or insufficient response or intolerance to other standard DMARDs in combination with or without MTX were enrolled in the study. 464 (89.4%) patients were randomized in a 2:1 ratio into two groups. The study and the reference drug were administered as an intravenous infusion at a dose of 8 mg/kg once every 4 weeks. The primary endpoint was the proportion of patients with an ACR20 after 24 weeks of therapy.Results and discussion. The proportion of responders in CPR group was 91.2%, and in ACT group – 90.7% (p = 0.866). The difference between the groups was 0.5% (95% CI: -5,2%−6,1%), which is fully within the declared boundaries of recognition of therapeutic equivalence. Comparability of the biosimilar CPR and the reference drug ACT is also confirmed by the results of secondary efficacy endpoints: the proportion of patients with ACR50/70, dynamics of the DAS28, SDAI, CDAI, the functional activity of patients (HAQ), laboratory parameters of inflammatory activity (ESR and CRP). Comparability of the study and the reference drugs is also demonstrated by the results of the safety analysis.Conclusion. Based on the results of the clinical study, it has been proven that CPR (JSC Generium, Russia) is a biological analogue of ACT (F. Hoffmann-La Roche Ltd., Switzerland).

11 October 2023 in Eurasian heart journal
Verified
Journal Article
Open access
PDF file
OIO. S. Ivanova
O. S. Ivanova
EME. Y. Maychuk
E. Y. Maychuk
IVI. V. Voevodina
I. V. Voevodina
IMI. A. Makarova
I. A. Makarova
EAE. V. Akatova
E. V. Akatova
ЕМЕ. Ю. Майчук
Е. Ю. Майчук
Objective: study of the relationship between arterial hypertension and arterial stiffness in women to identify potential markers of target organ damage and therapeutic targets of antihypertensive therapy.Materials  and methods: the study involved 161 women who were divided into three groups depending on age and reproductive function. Group 1 consisted of 52 women aged 18 to 30; group 2 – 54 women aged 31 years before menopause; 3rd group – 55 women in the postmenopausal period. All women were questioned, clinical examination, determination of anthropometric data, measurement of carotid-femoral pulse wave velocity, determination of arterial stiffness by volumetric sphygmography, 24-hour blood pressure monitoring with assessment of aortic stiffness and characteristics of the central pulse wave.Results: 24-hour blood pressure monitoring revealed arterial hypertension in 38 (34,8%) women: 15 (27,8%) women in the 2nd group and 23 (41,8%) women in the 3rd group. Correlation analysis revealed the most significant correlations between the presence of arterial hypertension (R=0,45-0,71; p<<0,01) with central aortic pressure, double product index and average daily aortic pulse wave velocity in the aorta (PWVao), regardless of the state reproductive function. For women of reproductive age with arterial hypertension, the ambulatory vascular stiffness index (AASI: R=0,36; p=0,01) is more significant, while in the menopausal period, the arterial stiffness index (ASI: R=0,33; p=0,01). Correlation analysis did not reveal significant relationships between carotid-femoral pulse wave velocity and cardio-ankle vascular index (CAVI) with arterial hypertension in women of the 2nd and 3rd groups. The relationship between carotid-femoral pulse wave velocity and arterial hypertension in women was confirmed by analysis of variance (p=0,007).Conclusion: Central aortic pressure, carotid-femoral pulse wave velocity, AASI, ASI, PWVao – direct and indirect indicators of arterial stiffness – are interconnected with the presence of arterial hypertension in women of reproductive and menopausal age. In this regard, these indicators are potential markers of target organ damage in arterial hypertension.

30 March 2026 in Clinical Psychology and Special Education
Verified
Journal Article
Open access
EPElena Pervichko
Elena Pervichko
EDE.V. Deshchenko
E.V. Deshchenko
OMOlga Mitina
Olga Mitina
EAE.V. Akatova
E.V. Akatova
MSM.A. Shikina
M.A. Shikina
Context and relevance. The diagnosis of cardiac disease in transport workers may be a reason for dismissal from work duties, becoming a source of frustration and imbuing the situation of illness with additional personal meaning for the patient. Understanding the role of psychological factors, particularly the patient`s personality, in the formation of adherence to treatment aims to solve the issue of insufficient effectiveness of cardiovascular therapy and encouraging health behavior. Objective: to study the role of psychological factors in adherence to treatment in patients with cardiovascular diseases. Hypothesis. The level of adherence to treatment in patients with cardiovascular diseases depends on psychological factors mediating the treatment process. Methods and materials. The sample consisted of 43 male patients hospitalised with various cardiac pathologies in “RZD-Medicine” Central Clinical Hospital (М = 49,40; SD = 7,71). To provide a complex assessment of psychological factors the Hospital Anxiety and Depression Scale (HADS), the Short Health Anxiety Inventory, the Brief Illness Perception Questionnaire, the Defense Mechanisms Rating Scales (DMRS-SR-30), as well as the Picture Frustration Test were used. Adherence was measured using the Questionnaire for Comprehensive Assessment of Treatment Adherence. Structural equation modeling according to the path analysis procedure was used to determine the influence of psychological factors on adherence to treatment. Results. The results showed that adherence to treatment in patients with cardiovascular disease is associated with greater vigilance to bodily sensations, defense maturity and use of need-persistent and intropunitive frustration reactions. New data on the relationship between treatment adherence and frustration reactions and patient’s mechanisms of psychological defense were obtained. Using structural modeling, we inferred a model of the indirect influence of the maturity of patient’s defense mechanisms on the adherence to treatment for cardiovascular diseases, mediated by the type of frustration reactions. Conclusions. Maturity of defenses can serve as a reliable predictor for the type of frustration reaction: mature defenses predetermine the response to frustration by seeking a solution to the problem, which in turn increases the likelihood of high adherence to treatment. Therefore, the results highlight the need for further research on the role of personality in forming adherence to treatment using a larger sample size.

2 June 2025 in Kardiologiia
Verified
Journal Article
Open access
PDF file
EAE. V. Akatova
E. V. Akatova
MSM. A. Shikina
M. A. Shikina
Cardiovascular diseases occupy one of the leading places in the structure of morbidity, mortality and disability of the population. Arterial hypertension (AH) is the major risk factor for the development of cardiovascular diseases. The problem of insufficient adherence to the treatment of AH remains unresolved in many countries. The administration of fixed combinations is a major way to increase adherence to antihypertensive therapy. In addition, the use of fixed combinations helps to improve the cardiovascular the prognosis in patients with AH by reducing the risk of developing cardiovascular complications.

25 September 2025 in Eurasian heart journal
Verified
Journal Article
Open access
PDF file
EAE. V. Akatova
E. V. Akatova
IMI. A. Makarova
I. A. Makarova
MSM. A. Shikina
M. A. Shikina
Cardiovascular diseases (CVD) occupy the first place in the structure of morbidity, mortality and disability of the population, therefore, the problem of effective treatment of CVD is still one of the most important in modern cardiology. CV diseases require lifelong therapy, so overcoming poor adherence is relevant in the treatment of patients. Suboptimal adherence is a proven risk factor that decreases the effectiveness of treatment, increases the risk of developing CV complications, as well as worsens the disease outcomes and quality of life. In addition, there is a large number of factors affecting adherence to treatment, which significantly complicates the solution of this problem. Coronary heart disease (CHD) due to high prevalence worldwide is a poorly managed risk factor for CV risk and death. Despite the wide range of available medications, adherence to therapy in CHD patients is extremely low and it is associated with an unfavorable CV prognosis. Prescription of adequate drug treatment improves the clinical condition of CHD patients and decreases the level of CV complications and death. Currently, there is no single strategy for improving adherence to treatment. There is a negative correlation between the level of adherence to therapy and the number of prescribed medications. According to current recommendations, one of the most reasonable ways to solve the problem of poor adherence to pharmacotherapy is prescribing single-pill combinations. The concept of using single-pill combinations is defined as the combination of several drugs contained in a single dosage form. This strategy helps to improve the control of several risk factors at the same time and reduce the risk of CV events. The results of many studies confirm the effectiveness of introducing single-pill combinations in the real clinical practice, since it simplifies the treatment regimen and leads to better CV prognosis by reducing the risk of developing CV complications. This literature review presents a modern view on the problem of adherence to treatment in CHD patients.